Financial News Feed

No summary available....

Read more

Advaxis (ADXS) closed the most recent trading day at $3.29, moving -0.3% from the previous trading session....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 2) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(announced a settlement agreement with Celgene Corporation (NASDAQ: CELG ) regarding its ANDA related to generic Revlimid pending before Health Canada) Down In The Dumps (Biotech stocks hitting 52-week lows on April 2) Evoke Pharma Inc (NASDAQ: EVOK )(FDA issued a complete response letter for Gimoti, which is being evaluated for treating symptoms in adult women with acute and recurrent diabetic gastroparesis. Stock In Focus Advaxis To Offer Common Stock Advaxis, Inc. (NASDAQ: ADXS ), which rallied sharply Monday in reaction to clinical trial updates, announced its intention to offer its common stock in an underwritten public offering. The company said it intends to use the net proceeds to fund its R&D initiatives and for general corporate purposes. The stock slid 15.59 percent to $4.98 in after-hours trading....

Read more

Advaxis down 26% on pricing stock offering
11:49am, Wednesday, 03'rd Apr 2019
No summary available....

Read more

PLAY, GME and ADXS among after hours movers
09:37pm, Tuesday, 02'nd Apr 2019
No summary available....

Read more

WBA, EVOK and UGI among premarket losers
01:17pm, Tuesday, 02'nd Apr 2019
No summary available....

Read more

Advaxis Inc. (NASDAQ:ADXS) and La Jolla Pharmaceutical Company (NASDAQ:LJPC) compete with each other in the Biotechnology sector. We will analyze and compare their institutional ownership, analyst rec...

Read more

Advaxis Inc. ( ADXS ) had a good day on the market for Monday April 01 as shares jumped 10.15% to close at $6.51. About 14.09 million shares traded hands on 70,821 trades for the day, compared with an...

Read more

These stocks jumped on a strong start to the second quarter....

Read more

These stocks jumped on a strong start to the second quarter....

Read more

Advaxis Inc. (NASDAQ:ADXS) and Assembly Biosciences Inc. (NASDAQ:ASMB) compete against each other in the Biotechnology sector. We will compare them and contrast their risk, institutional ownership, an...

Read more

Shares of Advaxis (NASDAQ:ADXS) soared Monday thanks to promising data from a Phase 1/2 Keynote-046 evaluating its cancer immunotherapy ADXS-PSA for the treatment of advanced prostate cancer. The 50-p...

Read more

The small-cap biotech reported encouraging news about its prostate cancer therapy....

Read more

The small-cap biotech reported encouraging news about its prostate cancer therapy....

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank